Clinical Trial Update: Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing everolimus with low-dose calcineurin inhibitor versus mycophenolate mofetil with full-dose CNI in heart transplant patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rejection After Heart Transplantation

Drugs mentioned

• Afinitor (everolimus) (everolimus)
• CELLCEPT (mycophenolate mofetil hydrochloride)
• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Rabin Medical Center | Conditions: Chronic Rejection of Cardiac Transplant | Phase 4 | Status: COMPLETED